Michelle Marchand
Psychiatric/Mental Health · Albany, NYNPI 1245871797
Payments from drug & device makers
Across 281 payments — averaging $27.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Axsome Therapeutics, Inc.$618
- Johnson & Johnson$572
- Supernus Pharmaceuticals, Inc.$528
- Alkermes, Inc.$430
- plus $3K from 15 others
What the payments were for
- Food & beverage$7,728100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $1,363 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 41 | $1,260 |
| Axsome Therapeutics, Inc. | 20 | $618 |
| Johnson & Johnson | 16 | $572 |
| Supernus Pharmaceuticals, Inc. | 15 | $528 |
| Alkermes, Inc. | 16 | $430 |
| Neurocrine Biosciences, Inc. | 18 | $411 |
| Corium, LLC | 16 | $408 |
| Otsuka America Pharmaceutical, Inc. | 7 | $353 |
| Lundbeck LLC | 12 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $309 |
| Ironshore Pharmaceuticals Inc. | 13 | $309 |
| Teva Pharmaceuticals USA, Inc. | 8 | $280 |
| Novo Nordisk | 3 | $168 |
| Vanda Pharmaceuticals Inc. | 8 | $155 |
| Eisai Inc. | 2 | $117 |
| Idorsia Pharmaceuticals US Inc | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,728 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Asenapine Maleate | 18 | $2,587 |
| Duloxetine Hcl | 36 | $576 |
| Lamotrigine | 20 | $276 |
| Olanzapine | 29 | $263 |
| Clonazepam | 22 | $223 |
| Alprazolam | 18 | $199 |
| Buspirone Hcl | 20 | $160 |
| Mirtazapine | 12 | $159 |
| Hydroxyzine Pamoate | 17 | $154 |
| Gabapentin | 16 | $134 |
| Escitalopram Oxalate | 11 | $83 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $32 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Albany
- Vera ImperialeAlbany$69K
- Patricia MuttererAlbany$18K
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Mary OlsonNew York$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.